Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

NovoLog (Insulin Aspart [rDNA origin] Injection)
Company:  Novo Nordisk Pharmaceuticals Inc.
Application No.:  20-986
Approval Date: 6/7/2000


Date created: April 30, 2002

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.